Fröhner M, Rübben H
Klinik und Poliklinik für Urologie, Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland,
Urologe A. 2015 Apr;54(4):510-5. doi: 10.1007/s00120-015-3777-4.
In Germany, bladder cancer is the fourth most common malignancy in males, while it occupies the 14th place in females. About 75% of cases occur in patients aged 65 or more years.
Elderly patients with nonmuscle-invasive bladder cancer appear to harbor a higher risk of disease recurrence and progression and should undergo the same treatment and careful surveillance as their younger counterparts. Elderly patients with muscle-invasive bladder cancer undergoing radical cystectomy are at an increased risk of perioperative morbidity and mortality and should be referred to experienced high-volume centers.
Beside radical cystectomy as standard treatment, several bladder-sparing approaches (transurethral resection, chemotherapy, radiotherapy, chemoradiotherapy) are available which may be treatment alternatives in carefully selected cases. Valid randomized comparisons between these approaches and radical cystectomy are, however, still lacking.
在德国,膀胱癌是男性中第四常见的恶性肿瘤,而在女性中则排在第14位。约75%的病例发生在65岁及以上的患者中。
非肌层浸润性膀胱癌老年患者似乎疾病复发和进展风险更高,应与年轻患者接受相同的治疗和仔细监测。接受根治性膀胱切除术的肌层浸润性膀胱癌老年患者围手术期发病率和死亡率增加,应转诊至经验丰富的大型中心。
除了根治性膀胱切除术作为标准治疗外,还有几种保留膀胱的方法(经尿道切除术、化疗、放疗、放化疗),在精心挑选的病例中可能是治疗选择。然而,这些方法与根治性膀胱切除术之间仍缺乏有效的随机对照比较。